Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 279 participants.
Also called NCT04511234
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 279 participants
- Sponsor
- Registry
-
NCT04511234
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Singapore, Taiwan, Thailand
- Registry status
- Recruiting
Technical summary
Registry record NCT04511234. Randomized; quadruple masking; primary purpose treatment. Start 2020-09-08 (actual); primary completion 2025-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
- Acronym
- FUTURE-SFA
- Condition
- Peripheral Artery Disease
- Condition
- Atherosclerosis
- Condition
- Arterial Disease
- Intervention (Device)
- MagicTouch PTA sirolimus drug coated balloon (DCB)
- Intervention (Device)
- POBA standard balloon
- Lead sponsor
- Concept Medical Inc.
Record details
- Record id
cardio:ct-nct04511234- Content hash
93e758d7a52d8b0995438e151956fc167191b1eaa8ea2a45bdde55f5969b7e94